Tissue Microarray Market - Overview

Market Research Future (MRFR)’s latest study reveals that the global tissue microarray market is set to expand saliently striking a CAGR of 10.88% during the forecast period 2017 to 2023.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/1213

Tissue microarray offers cost-benefit and time efficiency compared to the traditional slide-by-slide tissue analysis. It is likely to accelerate its adoption in the healthcare sector over the next couple of years.

Tissue microarray market benefits from the treatment’s potential to study a wide range of tumors at different phases of disease progression. Tissue microarray has developed an application in diagnosis of cancer through basic research, prognostic oncology, and drug discovery. The rising burden of cancer is one of the major factors favoring the expansion of the tissue microarray market.

Tissue microarray is an efficient tool for identification of new diagnostic and prognostic markers. Its extensive application in drug discovery and research & development is one of the major factors projected to drive the tissue microarray market proliferation over the assessment period.

The developments introduced in tissue microarray techniques have simplified the discovery of potential molecular targets for gene-specific therapy which is anticipated to complement the expansion of the market. Nevertheless, its inefficiency for heterogeneous cancer remains an impediment to the market growth.

Tissue Microarray Market - Competitive Dashboard:

Some of the key players profiled in the report are Illumina, Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Protein Biotechnologies Inc., Takara Bio, Perkin Elmer, Agilent Technologies, Merck Sharp & Dohme Corp, and General Electric.

Industry News:

In April 2018, Cancer Genetics, a biotech company, announced the receipt of special 510(k) clearance from Food & Drug Administration (FDA), the U.S., for Tissue of Origin (TOO) gene expression test. The microarray-based test identifies a tumor's tissue of origin by assessing 2,000 individual genes.

Check Discount at https://www.marketresearchfuture.com/check-discount/1213

In June 2018, Philips, a Dutch multinational company, launched Xplore a web-based image and data management platform. It allows labs to store tissue microarray studies and promotes knowledge sharing among researchers.

Tissue Microarray Market - Regional Analysis:

By region, the global tissue microarray market has been segmented into Asia Pacific, Americas, Europe, and the Middle East & Africa. Americas is poised to retain a dominant share of the market towards the end of the forecast period. The growth of the region is attributable to the presence of key players, rising healthcare expenditures, adoption of latest technologies in the healthcare sector, and rising burden of cancer among others.

Europe is estimated to control the second largest share of the market. The developed healthcare of the region coupled with government support for research & development has augmented the tissue microarray market in the region. The trend is likely to perpetuate in the foreseeable future.

Asia Pacific is expected to grow at a relatively higher CAGR during the projection period. The favorable factors of growth of the regional tissue microarray market include the presence of fast-developing economies such as India & China, increasing healthcare expenditure, developing healthcare sector, government’s initiatives to boost medical tourism, etc.

The Middle East & Africa is expected to exhibit sluggish growth. Although the African regions remain laggards, the developments in the healthcare sector of the Middle Eastern countries are set to earn some profits in the forthcoming years.

Tissue Microarray Market - Segmentation:

By procedure, the global tissue microarray market is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.

By technology, the tissue microarray market has been segmented into DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.

By application, the global tissue microarray market is segmented into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.

By end-user, the tissue microarray market has been segmented into pharmaceutical and biotechnological companies, research organization, and others.

Major TOC of Tissue Microarray Market Research Report - Global Forecast till 2023:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Tissue Microarray Market, By Procedure

TOC CONTINUED…

Ask Any Question at https://www.marketresearchfuture.com/enquiry/1213

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]